VIVA BIOTECH 01873·

Gross margin ----56.11%--58.14%2.03%50.21%7.93%--------30.94%--34.28%3.34%34.26%0.02%34.60%0.34%37.91%3.30% Net margin ----25.36%--51.44%26.08%43.11%8.33%--------14.28%---21.19%35.47%-4.63%16.56%11.17%15.80%15.57%4.40% ROE ------------------------7.35%---14.66%22.01%-3.15%11.51%4.40%7.55%5.50%1.10% ROA ----24.04%--37.68%13.64%17.11%20.57%--------3.74%---6.37%10.10%-1.34%5.03%3.15%4.49%3.74%0.59% Revenue growth --------53.63%--41.68%11.95%------------13.10%---9.42%22.51%-7.84%1.58%-12.95%5.11% Attributable profit growth --------211.61%--18.74%192.87%-------------283.79%--78.03%361.82%244.08%166.05%31.36%212.72% Debt-to-assets ----24.87%--24.53%0.34%52.50%27.97%--------51.36%--54.49%3.14%50.50%3.99%45.87%4.62%44.35%1.52% Current ratio ----3.99--2.261.745.683.42--------2.14--0.731.421.320.601.560.231.510.05 Operating cash flow / net profit ----0.86--0.370.500.130.23--------0.26---0.771.02-3.843.081.685.530.860.82 Operating cash flow / revenue ----21.89%--18.81%3.07%5.77%13.05%--------3.70%--16.22%12.52%17.79%1.56%18.83%1.04%13.43%5.40%

Gross margin 40.80%--33.95%6.85% Net margin 17.87%--10.02%7.85% Revenue growth ----20.99%-- Attributable profit growth -----34.26%-- Debt-to-assets ----42.38%-- Current ratio ----1.54-- Operating cash flow / net profit 0.87--3.432.56 Operating cash flow / revenue 15.61%--34.38%18.77%

Revenue ----96.49M--148.25M53.63%210.03M41.68%--------2.10B--2.38B13.10%2.16B9.42%1.99B7.84%1.73B12.95% Other income and gains ----7.09M--6.41M9.54%4.67M27.15%--------123.44M--67.65M45.20%87.05M28.69%81.70M6.14%46.54M43.03% Cost of sales ----42.35M--62.06M46.53%104.58M68.52%---------------------------- Gross profit ----54.14M--86.19M59.19%105.46M22.36%--------650.98M--815.68M25.30%738.43M9.47%687.40M6.91%655.56M4.63% Selling and distribution expenses ----1.39M--2.02M44.90%3.92M94.60%--------93.97M--130.80M39.19%132.55M1.33%112.23M15.33%101.11M9.91% Administrative expenses ----12.83M--15.23M18.72%25.58M67.95%--------226.31M--273.65M20.92%277.11M1.26%251.89M9.10%262.80M4.33% Net finance costs ----203.00K--853.00K320.20%557.00K34.70%--------183.11M--184.67M0.86%176.58M4.38%53.89M69.48%37.52M30.38% Income tax ----3.95M--10.55M167.32%15.31M45.11%--------47.14M--45.05M4.43%43.84M2.70%73.72M68.16%48.73M33.89% Operating profit ------------------------530.81M---274.49M151.71%120.63M143.95%349.69M189.89%360.02M2.95% Share of associates and JVs -----3.40M---4.11M20.83%-3.25M21.06%---------------------95.00K---4.50M4633.68% Profit before tax ----28.42M--86.81M205.46%105.86M21.94%--------347.70M---459.17M232.06%-55.95M87.81%295.70M628.49%318.00M7.54% Net profit ----24.47M--76.26M211.61%90.55M18.74%--------300.56M---504.22M267.76%-99.79M80.21%221.99M322.45%269.27M21.30% Net profit attributable to owners ------------------------287.55M---528.48M283.79%-116.11M78.03%167.29M244.08%219.76M31.36%

Revenue 831.87M--1.01B20.99% Other income and gains 24.87M--17.97M27.77% Cost of sales 492.45M--664.79M35.00% Gross profit 339.43M--341.73M0.68% Selling and distribution expenses 57.68M--49.91M13.47% Administrative expenses 126.04M--121.99M3.21% Net finance costs 18.51M--15.19M17.94% Income tax 23.06M--8.72M62.19% Share of associates and JVs -418.00K---297.00K28.95% Profit before tax 171.69M--109.60M36.17% Net profit 148.64M--100.88M32.13% Net profit attributable to owners 121.81M--80.08M34.26%

Cash and cash equivalents ----13.43M--29.77M121.72%155.55M422.59%--------800.95M--678.57M15.28%1.04B52.72%941.71M9.13%1.09B15.62% Trade and bills receivables ----24.06M--36.88M53.24%68.41M85.52%--------429.70M--445.97M3.79%407.40M8.65%420.46M3.21%386.30M8.12% Inventories ----1.01M--3.32M228.04%4.90M47.46%--------231.72M--326.03M40.70%259.71M20.34%272.70M5.00%335.74M23.12% Total current assets ----65.16M--83.45M28.06%241.17M189.01%--------1.98B--1.94B2.27%2.03B4.75%1.75B13.59%2.13B21.27% Total assets ----101.82M--202.40M98.78%529.34M161.53%--------8.04B--7.92B1.54%7.45B5.95%7.05B5.36%7.20B2.11% Total current liabilities ----16.32M--36.99M126.66%42.46M14.79%--------926.60M--2.67B188.43%1.53B42.60%1.13B26.56%1.41B25.25% Total liabilities ----25.32M--49.64M96.06%277.90M459.82%--------4.13B--4.32B4.47%3.76B12.84%3.23B14.03%3.19B1.28% Equity attributable to owners ------------------------3.91B--3.60B7.89%3.69B2.31%3.80B3.10%4.00B5.11% Total equity ----76.50M--152.76M99.68%251.44M64.60%--------3.91B--3.60B7.89%3.69B2.31%3.82B3.48%4.01B4.98%

Cash and cash equivalents ----1.00B-- Trade and bills receivables ----250.50M-- Inventories ----398.69M-- Total current assets ----1.82B-- Total assets ----6.89B-- Total current liabilities ----1.18B-- Total liabilities ----2.92B-- Equity attributable to owners ----3.96B-- Total equity ----3.97B--

Net cash from operating activities ----21.12M--27.89M32.07%12.11M56.58%--------77.83M--386.05M396.02%383.40M0.69%373.99M2.46%232.22M37.91% Net cash from investing activities -----19.59M---9.76M50.17%-69.95M616.54%---------868.84M---372.80M57.09%439.17M217.80%185.90M57.67%-79.59M142.81% Net cash from financing activities -----741.00K---849.00K14.57%179.48M21240.05%---------653.16M---143.20M78.08%-429.50M199.94%-657.76M53.15%204.00K100.03% Net change in cash ----788.00K--17.28M2092.89%121.64M603.94%---------1.44B---129.95M91.00%393.08M402.49%-97.88M124.90%152.84M256.16%

Net cash from operating activities 129.82M--346.03M166.54% Net cash from investing activities -14.15M--129.73M1016.86% Net cash from financing activities -151.99M---544.09M257.98% Net change in cash -36.31M---68.34M88.18%